110 related articles for article (PubMed ID: 8442017)
1. Relative potency of chlorinated dibenzo-p-dioxins (CDDs) in acute, subchronic and chronic (carcinogenicity) toxicity studies: implications for risk assessment of chemical mixtures.
Rozman K; Roth WL; Greim H; Stahl BU; Doull J
Toxicology; 1993 Jan; 77(1-2):39-50. PubMed ID: 8442017
[TBL] [Abstract][Full Text] [Related]
2. Comparative toxicity of four chlorinated dibenzo-p-dioxins (CDDs) and their mixture. Part I: Acute toxicity and toxic equivalency factors (TEFs).
Stahl BU; Kettrup A; Rozman K
Arch Toxicol; 1992; 66(7):471-7. PubMed ID: 1444813
[TBL] [Abstract][Full Text] [Related]
3. Comparative toxicity of four chlorinated dibenzo-p-dioxins (CDDs) and their mixture. IV. Determination of liver concentrations.
Rozman KK; Stahl BU; Kerecsen L; Kettrup A
Arch Toxicol; 1995; 69(8):547-51. PubMed ID: 8534198
[TBL] [Abstract][Full Text] [Related]
4. Subchronic/chronic toxicity of a mixture of four chlorinated dibenzo-p-dioxins in rats. I. Design, general observations, hematology,and liver concentrations.
Viluksela M; Stahl BU; Birnbaum LS; Schramm KW; Kettrup A; Rozman KK
Toxicol Appl Pharmacol; 1998 Jul; 151(1):57-69. PubMed ID: 9705887
[TBL] [Abstract][Full Text] [Related]
5. Comparative toxicity of four chlorinated dibenzo-p-dioxins (CDDs) and their mixture. Part III: Structure-activity relationship with increased plasma tryptophan levels, but no relationship to hepatic ethoxyresorufin o-deethylase activity.
Weber LW; Lebofsky M; Stahl BU; Kettrup A; Rozman K
Arch Toxicol; 1992; 66(7):484-8. PubMed ID: 1332652
[TBL] [Abstract][Full Text] [Related]
6. Subchronic/chronic toxicity of a mixture of four chlorinated dibenzo-p-dioxins in rats. II. Biochemical effects.
Viluksela M; Stahl BU; Birnbaum LS; Rozman KK
Toxicol Appl Pharmacol; 1998 Jul; 151(1):70-8. PubMed ID: 9705888
[TBL] [Abstract][Full Text] [Related]
7. Comparative toxicity of four chlorinated dibenzo-p-dioxins (CDDs) and their mixture. Part II: Structure-activity relationships with inhibition of hepatic phosphoenolpyruvate carboxykinase, pyruvate carboxylase, and gamma-glutamyl transpeptidase activities.
Weber LW; Lebofsky M; Stahl BU; Kettrup A; Rozman K
Arch Toxicol; 1992; 66(7):478-83. PubMed ID: 1359853
[TBL] [Abstract][Full Text] [Related]
8. Reduced activity of tryptophan 2,3-dioxygenase in the liver of rats treated with chlorinated dibenzo-p-dioxins (CDDs): dose-responses and structure-activity relationship.
Weber LW; Palmer CD; Rozman K
Toxicology; 1994 Jan; 86(1-2):63-9. PubMed ID: 7907825
[TBL] [Abstract][Full Text] [Related]
9. Toxicology and carcinogenesis studies of 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (CAS No. 31508-00-6) in female harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2010 Nov; (559):1-174. PubMed ID: 21383778
[TBL] [Abstract][Full Text] [Related]
10. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
11. Toxic equivalency factors do not predict the acute toxicities of dioxins in rats.
Pohjanvirta R; Unkila M; Lindén J; Tuomisto JT; Tuomisto J
Eur J Pharmacol; 1995 Dec; 293(4):341-53. PubMed ID: 8748687
[TBL] [Abstract][Full Text] [Related]
12. Relative potency values derived from hepatic vitamin A reduction in male and female Sprague-Dawley rats following subchronic dietary exposure to individual polychlorinated dibenzo-p-dioxin and dibenzofuran congeners and a mixture thereof.
Fattore E; Trossvik C; Håkansson H
Toxicol Appl Pharmacol; 2000 Jun; 165(3):184-94. PubMed ID: 10860868
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of the biological effects of PCBs, polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans in experimental animals.
Neal RA
Environ Health Perspect; 1985 May; 60():41-6. PubMed ID: 2992926
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships and dose responses of polychlorinated dibenzo-p-dioxins for short-term effects in 2,3,7,8-tetrachlorodibenzo-p-dioxin-resistant and -sensitive rat strains.
Simanainen U; Tuomisto JT; Tuomisto J; Viluksela M
Toxicol Appl Pharmacol; 2002 May; 181(1):38-47. PubMed ID: 12030841
[TBL] [Abstract][Full Text] [Related]
15. Subchronic/chronic toxicity of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (HpCDD) in rats. Part I. Design, general observations, hematology, and liver concentrations.
Viluksela M; Stahl BU; Birnbaum LS; Schramm KW; Kettrup A; Rozman KK
Toxicol Appl Pharmacol; 1997 Oct; 146(2):207-16. PubMed ID: 9344888
[TBL] [Abstract][Full Text] [Related]
16. Chronic toxicity and carcinogenicity of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin displays a distinct dose/time toxicity threshold (c x t = k) and a life-prolonging subthreshold effect.
Rozman KK; Lebofsky M; Pinson DM
Food Chem Toxicol; 2005 May; 43(5):729-40. PubMed ID: 15778013
[TBL] [Abstract][Full Text] [Related]
17. NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 May; (529):4-168. PubMed ID: 16835634
[TBL] [Abstract][Full Text] [Related]
18. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
[TBL] [Abstract][Full Text] [Related]
19. Gingival carcinogenicity in female Harlan Sprague-Dawley rats following two-year oral treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like compounds.
Yoshizawa K; Walker NJ; Jokinen MP; Brix AE; Sells DM; Marsh T; Wyde ME; Orzech D; Haseman JK; Nyska A
Toxicol Sci; 2005 Jan; 83(1):64-77. PubMed ID: 15509667
[TBL] [Abstract][Full Text] [Related]
20. Chlorination of Irgasan DP300 and formation of dioxins from its chlorinated derivatives.
Kanetoshi A; Ogawa H; Katsura E; Kaneshima H
J Chromatogr; 1987 Feb; 389(1):139-53. PubMed ID: 3571350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
